Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8YMY3

Entry ID Method Resolution Chain Position Source
AF-Q8YMY3-F1 Predicted AlphaFoldDB

No variants for Q8YMY3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8YMY3

No associated diseases with Q8YMY3

3 regional properties for Q8YMY3

Type Name Position InterPro Accession
domain Translation elongation factor EFTs/EF1B, dimerisation 73 - 293 IPR014039
conserved_site Translation elongation factor Ts, conserved site 12 - 27 IPR018101-1
conserved_site Translation elongation factor Ts, conserved site 77 - 87 IPR018101-2

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
translation elongation factor activity Functions in chain elongation during polypeptide synthesis at the ribosome.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAEISAKLVQ ELRQKTGAGM MDCKKALKET EGDVEQAIDW LRKKGIASAG KKSDRIAAEG
70 80 90 100 110 120
LVDTYIQPGG KVGVLIEVNC QTDFVARNDA FKTLVKNLAQ QAATADSVES LLAQPYIEDA
130 140 150 160 170 180
NLTVDEAIKQ TIANLGENIQ VRRFINFALT DKTGVVDSYI HTGGRVGVLV ELNSQSEAGA
190 200 210 220 230 240
ANEEVQNLAR NAAMQVAACP NVEYVSVDQI PAEVVQREKD VESGKEDIAN KPENIREKIV
250 260 270 280 290 300
QGRIEKRLKE LTLVDQPYIR DQSISVEDLV KQVKAKAGEE VEVSRFVRYI LGEGIEKQES
310
NFAEEVAAQM GVK